一般演題口演 CKD（臨床）1

[O-089] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes

Terumasa Hayashi¹, Shweta Bansal², Stefan D. Anker³, George L. Bakris⁴, Peter Rossing⁵, Rita Birne⁶, Maria E. F. Canziani⁷, Alfredo E. Farjat⁸, Meike Brinker⁹, Bertram Pitt¹⁰ (1.Osaka General Medical Center, Japan, 2.University of Texas Health San Antonio, USA, 3.Charité Universitätsmedizin, Germany, 4.University of Chicago Medicine, USA, 5.Steno Diabetes Center Copenhagen, Denmark, 6.Centro Hospitalar Lisboa Ocidental, Portugal, 7.Federal University of São Paulo, Brazil, 8.Bayer PLC, UK, 9.Bayer AG, Germany, 10.University of Michigan School of Medicine, USA)